Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-08-09 5:00 pm Sale | 13D | DICE Therapeutics, Inc. DICE | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -7,877,862 (Position Closed) | View |
| 2023-07-10 10:20 am Sale | 13G | DICE Therapeutics, Inc. DICE | FMR LLC | 2,239,223 4.688% | -2,958,134 (-56.92%) | View |
| 2023-06-23 5:10 pm Sale | 13D | DICE Therapeutics, Inc. DICE | Northpond Ventures LP | 800,000 1.700% | -2,492,871 (-75.71%) | View |
| 2023-06-22 4:32 pm Sale | 13D | DICE Therapeutics, Inc. DICE | Sands Capital Life Sciences Pulse Fund II L.P. | 1,886,470 4.000% | -1,262,500 (-40.09%) | View |
| 2023-06-21 5:00 pm Purchase | 13D | DICE Therapeutics, Inc. DICE | RA CAPITAL MANAGEMENT L.P. | 7,877,862 16.500% | 217,247 (+2.84%) | View |
| 2023-03-29 5:14 pm Purchase | 13D | DICE Therapeutics, Inc. DICE | RA CAPITAL MANAGEMENT L.P. | 7,660,615 16.100% | 811,704 (+11.85%) | View |
| 2023-02-14 12:38 pm Purchase | 13G | DICE Therapeutics, Inc. DICE | PRICE T ROWE ASSOCIATES INC | 3,219,960 6.800% | 3,219,960 (New Position) | View |
| 2023-02-14 09:32 am Purchase | 13G | DICE Therapeutics, Inc. DICE | Scott Epstein | 2,525,555 5.300% | 2,525,555 (New Position) | View |
| 2023-02-13 2:27 pm Purchase | 13G | DICE Therapeutics, Inc. DICE | BlackRock Inc. BLK | 3,052,102 6.400% | 3,052,102 (New Position) | View |
| 2023-02-09 09:59 am Sale | 13G | DICE Therapeutics, Inc. DICE | FMR LLC | 5,197,357 10.902% | -96,658 (-1.83%) | View |
| 2022-11-10 4:15 pm Unchanged | 13D | DICE Therapeutics, Inc. DICE | Northpond Ventures LP | 3,292,871 6.900% | 0 (Unchanged) | View |
| 2022-11-10 11:55 am Purchase | 13G | DICE Therapeutics, Inc. DICE | FMR LLC | 5,294,015 11.107% | 5,294,015 (New Position) | View |
| 2022-11-10 09:23 am Sale | 13G | DICE Therapeutics, Inc. DICE | DRIEHAUS CAPITAL MANAGEMENT LLC | 1,915,496 4.020% | -231,146 (-10.77%) | View |
| 2022-10-19 4:37 pm Purchase | 13D | DICE Therapeutics, Inc. DICE | RA CAPITAL MANAGEMENT L.P. | 6,848,911 14.400% | 1,640,000 (+31.48%) | View |
| 2022-02-14 09:24 am Purchase | 13G | DICE Therapeutics, Inc. DICE | DRIEHAUS CAPITAL MANAGEMENT LLC | 2,146,642 5.610% | 2,146,642 (New Position) | View |
| 2021-09-28 06:04 am Purchase | 13D | DICE Therapeutics, Inc. DICE | Northpond Ventures LP | 3,292,871 9.100% | 3,292,871 (New Position) | View |
| 2021-09-27 4:32 pm Purchase | 13D | DICE Therapeutics, Inc. DICE | RA CAPITAL MANAGEMENT L.P. | 5,208,911 14.300% | 5,208,911 (New Position) | View |
| 2021-09-24 6:12 pm Purchase | 13D | DICE Therapeutics, Inc. DICE | Sands Capital Life Sciences Pulse Fund II L.P. | 3,148,970 8.700% | 3,148,970 (New Position) | View |